Prescription drug · UNAPPROVED DRUG OTHER
Obagi-C Rx system C-Therapy Night Skin Lightening with Vitamins C and E NDC 62032-105
hydroquinone · Hydroquinone 40 mg/g · Cream · Topical · Obagi Cosmeceuticals LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 62032-105-36 | 62032010536 | 57 g in 1 BOTTLE, PLASTIC (62032-105-36)Marketed from Jan 1, 2010 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Obagi-C Rx system C-Therapy Night Skin Lightening with Vitamins C and ESuffix: Skin Lightening with Vitamins C and E
- Generic name (nonproprietary)
- hydroquinone
- Active ingredients
- Hydroquinone — 40 mg/g
- Dosage form
- Cream
- Route
- Topical
- Labeler
- Obagi Cosmeceuticals LLC
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Depigmenting Activity (Physiologic effect)Melanin Synthesis Inhibitors (Mechanism)
- Identifiers
- Product ID 62032-105_2e9d9417-8b73-4d00-9783-c0d14f1a9cbcSPL ID 2e9d9417-8b73-4d00-9783-c0d14f1a9cbcSPL set ID 81e2e734-01fe-4568-903a-92993bf40887RxCUI 197795UNII XV74C1N1AE
- Pharmacologic class
- Melanin Synthesis Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N462032010536followed by a unit qualifier and the quantityPackage 62032-0105-36. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE The gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation.
Excerpt only. Read the full label for complete information.